儿童期哮喘对学龄儿童肥胖发展的影响
该研究基于南加州儿童健康研究(CHS)队列,纳入2,171名入组时5-8岁非肥胖儿童并随访长达10年,另在2,684名独立样本中重复验证。结果显示,入组时确诊哮喘的儿童发生肥胖的风险增加51%(HR 1.51,95%CI 1.08-2.10),而使用哮喘缓解药物与肥胖风险降低相关(HR 0.57,95%CI 0.33-0.96),该关联在独立样本中得到重复。
要点
- 儿童期哮喘与后续肥胖风险增加相关(HR 1.51,95%CI 1.08-2.10)。
- 使用哮喘缓解药物与肥胖风险降低相关(HR 0.57,95%CI 0.33-0.96)。
- 该关联在独立CHS样本中重复验证,提示需关注哮喘儿童体重管理。
核心结论
- 患有哮喘的儿童可能面临更高的肥胖风险。
- 使用哮喘缓解药物似乎可独立于体力活动降低肥胖风险。
- 哮喘病史与肥胖风险增加的显著关联在独立CHS样本中得到重复。
研究设计与样本
- 主要分析纳入南加州儿童健康研究(CHS)中2,171名入组时5-8岁且非肥胖的儿童,随访长达10年。
- 重复分析在2,684名独立CHS儿童样本中进行,随访从平均9.7岁至17.8岁。
- 每年测量身高体重以分类正常、超重和肥胖,哮喘状态由家长或自我报告的医生诊断确定。
- 采用Cox比例风险模型评估哮喘病史与随访期间肥胖发病率的关联。
主要发现
- 入组时确诊哮喘的儿童相比无哮喘儿童,在儿童期和青春期发生肥胖的风险增加51%(HR 1.51;95%CI 1.08-2.10),已调整混杂因素。
- 入组时使用哮喘缓解药物与肥胖风险降低相关(HR 0.57;95%CI 0.33-0.96)。
- 哮喘病史与肥胖风险增加的显著关联在独立CHS样本中得到重复。
临床怎么用
- 对哮喘儿童应关注体重变化,警惕肥胖发生风险。
- 哮喘缓解药物的使用可能与降低肥胖风险相关,但需结合临床评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RATIONALE: Asthma and obesity often occur together in children. It is unknown whether asthma contributes to the childhood obesity epidemic. OBJECTIVES: We aimed to investigate the effects of asthma and asthma medication use on the development of childhood obesity. METHODS: The primary analysis was conducted among 2,171 nonobese children who were 5-8 years of age at study enrollment in the Southern California Children's Health Study (CHS) and were followed for up to 10 years. A replication analysis was performed in an independent sample of 2,684 CHS children followed from a mean age of 9.7 to 17.8 years. MEASUREMENTS AND MAIN RESULTS: Height and weight were measured annually to classify children into normal, overweight, and obese categories. Asthma status was ascertained by parent- or self-reported physician-diagnosed asthma. Cox proportional hazards models were fitted to assess associations of asthma history with obesity incidence during follow-up. We found that children with a diagnosis of asthma at cohort entry were at 51% increased risk of developing obesity during childhood and adolescence compared with children without asthma at baseline (hazard ratio, 1.51; 95% confidence interval, 1.08-2.10) after adjusting for confounders. Use of asthma rescue medications at cohort entry reduced the risk of developing obesity (hazard ratio, 0.57; 95% confidence interval, 0.33-0.96). In addition, the significant association between a history of asthma and an increased risk of developing obesity was replicated in an independent CHS sample. CONCLUSIONS: Children with asthma may be at higher risk of obesity. Asthma rescue medication use appeared to reduce obesity risk independent of physical activity.
引用
- Chen Z, Salam MT, Alderete TL, et al. Effects of Childhood Asthma on the Development of Obesity among School-aged Children. Am J Respir Crit Care Med. 2017. PMID: 28103443. doi:10.1164/rccm.201608-1691OC
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。